Taiwan Provisionally Approves Dexamethasone As Coronavirus Treatment


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ taiwan-provisionally-approves-dexamethasone-coronavirus-treatment
Taiwan has reported 476 cases of the new coronavirus, including seven deaths.

Taiwan temporarily affirmed the utilization of dexamethasone, a modest and broadly utilized steroid, to treat the new coronavirus, as the island faces a deficiency of the antiviral medication redeliver after the United States purchased about every single worldwide gracefully.

Taiwan Centers for Disease Control Deputy Director-General Chuang Jen-Hsiang told journalists on Tuesday that clinical specialists had chosen to temporarily permit dexamethasone to be recorded as a COVID-19 treatment however that systems despite everything should have been finished before it could be given to any patients.

Taiwan has detailed 476 instances of the new coronavirus, including seven passings. The greater part of the cases is imported and practically all have recouped. It has kept numbers low gratitude to ahead of schedule and successful counteraction work.

Taiwan's authentic Central News Agency said for the current week that stocks on the island of US drugmaker Gilead's COVID-19 medication remdesivir were low.

Taiwan had initially requested 2,000 dosages to show up before the finish of July, yet had just 78 in stock, enough to treat 54 genuinely sick patients, the report said.

Remdesivir is the main medication so far approved in the European Union to treat patients with extreme side effects of COVID-19.

Remdesivir is sought after the intravenously-managed medication-assisted with shortening emergency clinic recuperation times in a clinical preliminary.

However, in results declared in June, a preliminary by specialists in the United Kingdom demonstrated dexamethasone as the main medication to spare the existence of COVID-19 patients in what researchers said was a significant forward leap in the coronavirus pandemic.

Japan a month ago additionally endorsed the utilization of dexamethasone to treat COVID-19.

Tags : #Taiwan #Dexamethasone #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026